Nida Mumtaz Khan, MD | |
401 N 17th St Ste 103, Allentown, PA 18104 | |
(610) 969-3070 | |
(610) 969-3073 |
Full Name | Nida Mumtaz Khan |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 10 Years |
Location | 401 N 17th St Ste 103, Allentown, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255745667 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | MD465213 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lehigh Valley Hospital | Allentown, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Customer satisfaction rises for hospital services and electric and natural gas utilities, according to a report released today by the American Customer Satisfaction Index (ACSI).
US Oncology, Inc., the nation's leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla. Dec. 4-7. Five other investigators in the US Oncology Research Network participated in a study that will be displayed as a poster during the conference.
A new clinical trial at The Children's Hospital at OU Medical Center will focus on ways to catch a debilitating eye disease before it's too late.
More than half a million children – or 1,400 to 1,600 each day – die from rotavirus, the most common cause of severe childhood diarrhea. Almost all of these deaths occur in developing countries, where lifesaving medical care may not be affordable or available to the families with the most critical needs. In addition, income loss due to the need for parents to take care of sick children can have a very significant economic burden on families that can least afford it.
Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.
› Verified 7 days ago
Entity Name | Lehigh Valley Physician Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Customer satisfaction rises for hospital services and electric and natural gas utilities, according to a report released today by the American Customer Satisfaction Index (ACSI).
US Oncology, Inc., the nation's leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla. Dec. 4-7. Five other investigators in the US Oncology Research Network participated in a study that will be displayed as a poster during the conference.
A new clinical trial at The Children's Hospital at OU Medical Center will focus on ways to catch a debilitating eye disease before it's too late.
More than half a million children – or 1,400 to 1,600 each day – die from rotavirus, the most common cause of severe childhood diarrhea. Almost all of these deaths occur in developing countries, where lifesaving medical care may not be affordable or available to the families with the most critical needs. In addition, income loss due to the need for parents to take care of sick children can have a very significant economic burden on families that can least afford it.
Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Nida Mumtaz Khan, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Nida Mumtaz Khan, MD 401 N 17th St Ste 103, Allentown, PA 18104 Ph: (610) 969-3070 |
News Archive
Customer satisfaction rises for hospital services and electric and natural gas utilities, according to a report released today by the American Customer Satisfaction Index (ACSI).
US Oncology, Inc., the nation's leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla. Dec. 4-7. Five other investigators in the US Oncology Research Network participated in a study that will be displayed as a poster during the conference.
A new clinical trial at The Children's Hospital at OU Medical Center will focus on ways to catch a debilitating eye disease before it's too late.
More than half a million children – or 1,400 to 1,600 each day – die from rotavirus, the most common cause of severe childhood diarrhea. Almost all of these deaths occur in developing countries, where lifesaving medical care may not be affordable or available to the families with the most critical needs. In addition, income loss due to the need for parents to take care of sick children can have a very significant economic burden on families that can least afford it.
Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.
› Verified 7 days ago
Irene Cherfas Tsyvine, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1739 W Fairmont St, Allentown, PA 18104 Phone: 610-437-4988 | |
William Michael Mclaughlin Jr., DO Ophthalmology Medicare: Medicare Enrolled Practice Location: 1251 S Cedar Crest Blvd, Suite 307, Allentown, PA 18103 Phone: 610-820-6320 Fax: 610-820-8376 | |
Lisa S Bunin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1611 Pond Rd, Ste 403, Allentown, PA 18104 Phone: 610-435-5333 Fax: 610-435-2253 | |
Robert Kiesel, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 400 N 17th St, Suite 200, Allentown, PA 18104 Phone: 610-433-2021 Fax: 610-433-7856 | |
Alan D Listhaus, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 400 N 17th St, Ste 101, Allentown, PA 18104 Phone: 610-433-0450 Fax: 610-433-4655 | |
Dr. Avani Shah, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 401 N 17th St, Ste 103, Allentown, PA 18104 Phone: 610-969-3070 Fax: 610-969-3073 | |
David A De Rose, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1251 South Cedar Crest Blvd, Suite 307, Allentown, PA 18103 Phone: 610-820-6320 Fax: 610-820-8376 |